Open AccessHigh serum lactate dehydrogenase and dyspnea: Positive predictors of adverse outcome in critical COVID-19 patients in Yichang
Author(s) -
Xiaoting Lv,
Yongping Zhu,
Aiguo Cheng,
Yongfeng Jin,
Haibo Ding,
Cai-Yun Wang,
Shuyu Zhang,
Gongping Chen,
Qingquan Chen,
Qicai Liu
Publication year - 2020
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v8.i22.5535
Subject(s) - medicine , lactate dehydrogenase , covid-19 , l lactate dehydrogenase , adverse effect , gastroenterology , pathology , enzyme , disease , biochemistry , chemistry , outbreak , infectious disease (medical specialty)
Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in China, constitutes a Public Health Emergency of International Concern. It is well known that COVID-19 patients may have increased serum lactate dehydrogenase (LDH) levels in the early stage. The clinical changes in LDH may have predictive value in disease evolution and prognosis in critically ill COVID-19 patients.